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Simple Summary: The quality and completeness of colonoscopies might be hampered by suboptimal
visualization; often leading to a CT colonography. Colon capsule endoscopy has been suggested as
an alternative to CT colonography following incomplete colonoscopy. Colon capsule endoscopy is
conducted by the ingestion of a video capsule, which then transmits pictures, allowing complete
visualization of the colon and rectum. In our study, we compared the completion rates and diagnostic
yields (detection of polyps) of colon capsule endoscopy with those of CT colonography by conducting
a systematic review with meta-analysis. We found that the completion rate of CT colonography was
slightly higher than that of colon capsule endoscopy, while the diagnostic yield of colon capsule
endoscopy was higher, especially when comparing findings of any size polyps. This knowledge
might aid clinicians when planning further diagnostics following incomplete colonoscopies.
Abstract: Following incomplete colonoscopy (IC) patients often undergo computed tomography
colonography (CTC), but colon capsule endoscopy (CCE) may be an alternative. We compared the
completion rate, sensitivity and diagnostic yield for polyp detection from CCE and CTC following
IC. A systematic literature search resulted in twenty-six studies. Extracted data included inter alia,
complete/incomplete investigations and polyp findings. Pooled estimates of completion rates of
CCE and CTC and complete colonic view rates (CCE reaching the most proximal point of IC) of
CCE were calculated. Per patient diagnostic yields of CCE and CTC were calculated stratified
by polyp sizes. CCE completion rate and complete colonic view rate were 76% (CI 95% 68–84%)
and 90% (CI 95% 83–95%). CTC completion rate was 98% (CI 95% 96–100%). Diagnostic yields
of CTC and CCE were 10% (CI 95% 7–15%) and 37% (CI 95% 30–43%) for any size, 13% (CI 95%
9–18%) and 21% (CI 95% 12–32%) for >5-mm and 4% (CI 95% 2–7%) and 9% (CI 95% 3–17%) for
>9-mm polyps. No study performed a reference standard follow-up after CCE/CTC in individuals
without findings, rendering sensitivity calculations unfeasible. The increased diagnostic yield of
CCE could outweigh its slightly lower complete colonic view rate compared to the superior CTC
completion rate. Hence, CCE following IC appears feasible for an introduction to clinical practice.
Therefore, randomized studies investigating CCE and/or CTC following incomplete colonoscopy
with a golden standard reference for the entire population enabling estimates for sensitivity and
specificity are needed.
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1. Introduction
During incomplete colonoscopy (IC), the scope rarely reaches the ascending colon (4–25%),
and colonoscopy is often terminated in the sigmoid colon (22–43%) [1–4] or the rectum (6–10%) [3,5],
necessitating further evaluation of the colon. Usually, this is performed by repeat colonoscopy or
computed tomography colonography (CTC). European guidelines suggest colon capsule endoscopy
(CCE) as another option for this purpose [6]. CTC and CCE can both be used to complement IC results,
because the proximal parts of the colon are visualized [5,7,8]. CTC may be more reliable for larger
lesions (>9 mm) than smaller [9]. If CCE is better for detecting small lesions compared to CTC, it may
still be inhibited by a completion rate that is dependent on the battery lifetime exceeding the total
transit time of the capsule. CCE after IC may not need to be complete if it is conclusive (i.e., has a
positive finding or reaches the most proximal point seen during the IC) [3,4,10,11]. The overall goal
should therefore be that individuals must have a complete colonic visualization following IC and CCE.
CTC is a well-established and widely implemented diagnostic method [12], whereas the clinical use of
CCE is still limited. The number of studies investigating CCE following IC have also been limited but
have increased in recent years [2,5,10,11].
The incompletion of colonoscopy is often ascribed to nonpassable segments, stenosis or other
obstacles of passage, which are thought to potentially increase the risk of capsule retention, since the
highest rate of capsule retention in small bowel capsule endoscopies has been due to obstructions [13].
Research from our unit has shown that the completion rates of CCE after IC (68%) and CCE in
patients in a surveillance program (67%) are comparable. Although, a higher proportion of inadequate
bowel cleanliness was seen following IC (22%) compared to patients in a surveillance program with
previous colonoscopy (7.8%) [5,14]. The CCE can be administered immediately after the IC [3]
(or after supplementary bowel preparation, if necessary) in the same unit, which seems patient-friendly.
Furthermore, CCE appear to be more tolerable for patients than CTC [15].
We aimed to investigate whether the quality of CCE is worse, equal to or better than that of CTC
after IC. Therefore, the aim of this systematic review with meta-analysis was to compare the completion
rate, sensitivity and diagnostic yield for polyps from CCE and CTC after IC.
2. Materials and Methods
2.1. Search Strategy
A systematic literature search was conducted in databases PubMed, Web of Science and Embase.
Three areas of search terms were defined: investigation, indication and study design. Investigation was
to identify studies comparing colonoscopy with CCE and/or CTC. Indication was to limit results to
references in which participants had undergone IC. Study design was to limit results to retro- or
prospective cohorts or clinical studies, paired studies (to identify studies testing CCE and CTC in the
same patient group), randomized controlled trials (RCTs) and case-control designs. Search terms within
each area were combined in search strings using the Boolean expression “OR”. The three areas were then
combined in strings using the Boolean “AND”. Free text search terms with truncation were included,
as well as indexed search terms identified in the databases’ thesauruses. The only limitation set was to
articles, journal articles and articles in the press (depending on search engine options). No limitation
for publication years was applied. The final literature search was conducted September 10, 2020.
Specific search strings are provided in Appendix A, with search strategy in Table A1.
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2.2. Inclusion and Exclusion Criteria
RCTs, paired studies, cohort or case-control studies describing an adult population (≥18 years)
where individuals have undergone IC followed by either CTC, CCE or both were included.
Studies including exclusively occlusive cancer patients were excluded, as this patient subgroup
might not be suitable for CCE diagnostics, rendering any clinical potential obsolete. Included were
only articles written in the English language.
2.3. Screening of References
References, including abstracts, were exported from each database and imported to Endnote™,
version X9 [16]. Duplicates were identified and excluded. Title and abstract of remaining references
were screened independently by two of three authors (M.K.W., S.J.H. or U.D.) and were excluded
if they did not meet the inclusion criteria. In case of discrepancy between screeners, the reference
remained included. Full-text manuscripts of references not excluded were retrieved and thoroughly
read by three of the authors (U.D., L.K. and E.P.) independently and were excluded if they did not
meet inclusion criteria. In case of discrepancies, the authors would reread the article and discuss it
again. If further discrepancy was evident, the first author (U.D.) would make the decision whether
or not to include the reference. The reference lists of included studies were screened by at least two
screeners (U.D., M.K.W., L.K. or E.P.), and any reference of possible relevance would be retrieved in
full-text, examined by three authors (U.D., L.K. and E.P.) and included if inclusion criteria were met,
and this process continued until exhaustion (snowballing). Reviewers were not blinded to authors and
institutions of the reviewed manuscripts.
2.4. Data Handling
From each included study, two individuals (U.D. and L.K.) independently extracted the data
needed for statistical analysis (Table 1). Differing interpretations were solved in the same manner as
with discrepancies regarding the inclusion of studies (see Section 2.3).
Table 1. Data extracted for statistical analyses. IC: incomplete colonoscopy, CCE: colon capsule
endoscopy and CTC: computed tomography colonography.
Number Description
I Number of individuals/investigations included in the study
II Number of individuals with an IC previous to CCE/CTC
III Individuals with polyp(s) (any size polyp, >5 mm polyp and >9 mm polyp)
IV Number of complete investigations
V Number of investigations that combined with IC achieved complete colonic view
VI True positive individuals (any size polyp, >5 mm polyp and >9 mm polyp)
VII True negative individuals (any size polyp, >5 mm polyp and >9 mm polyp)
VIII False positive individuals (any size polyp, >5 mm polyp and >9 mm polyp)
IX False negative individuals (any size polyp, >5 mm polyp and >9 mm polyp)
Completion rates were then calculated as proportions of investigations in the studies (I) that were
complete (IV (V for a complete colonic view rate in CCE)). Sensitivities were to be calculated as true
positives (VI) divided by true positives (VI) and false negatives (IX) summed. Diagnostic yields were
calculated as proportions of individuals (I) who had at least one polyp, one polyp >5 mm or one polyp
>9 mm (III), respectively. Polyp sizes reported in the studies were assumed to follow the standard of
reporting the largest diameter of the lesions.
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Additional descriptive data were extracted for subgroup analyses. However, due to an
insufficient number of articles within each stratum, these analyses could not be performed.
For this reason, only some of these data were used for descriptive reasons. These data included
the first author, publication year, data origin (country), year of data collection, study type,
visualization instrument(s) (type of scanner or capsule), indications for colonoscopy, single- or
multi-center study, reported bowel/procedure preparation medicine (incl. boosters and contrast
agents), type of reference standard, whether the study included occlusive cancer patients or patients
with stenosis or other obstructions, gender distribution and mean age.
In cases of doubt on the meaning or phrasing in an article, a precautionary principle was applied,
and the information would not be included in the analyses. Therefore, an article clearly reporting
the number of polyps found but being vague about the sizes would only be included for the analysis
of polyps of any size. Furthermore, studies being exact with the number of total polyps but unclear
on the distribution of polyps in the population would be excluded from diagnostic yield analyses
but could still be included for completion rate analyses. Studies not explicitly stating the number of
complete or incomplete investigations were not included for analysis of completion rates.
2.5. Pooled Statistical Analysis
The proportion of patients with true polyp detection out of the total number of patients with polyp
detection (per patient sensitivity) of CCE and CTC was compared using studies with reference standard
follow-ups (second colonoscopy) stratified by polyp sizes. We calculated the completion rates of CTC
and CCE, as well as the complete colonic visualization rate of CCE following IC. Significance level
was set at 5%, and 95% confidence intervals were calculated. All pooled estimates were calculated
from patient data of included studies in random effects models using the Freeman-Tukey double
arcsine transformation.
Heterogeneity was tested by performing I2 statistics to test the consistency of results and evaluated
by applying thresholds provided by the Cochrane Handbook [17]. As no limit was applied to the
publication year of included articles, a sensitivity analysis for the diagnostic yield of any size polyps,
as well as completion rates, was conducted, including only studies published in the last decade (2010
and later).
Publication bias and small study effects were investigated using Egger’s test [18] and illustrated by
funnel plots for completion rate, diagnostic yield and sensitivity. All results from the included studies
were extracted and compiled in spreadsheets. All data analyses were conducted using Stata 16 [19]
including the Metaprop command [20].
3. Results
The initial literature search resulted in a total of 1814 references. Duplicates were removed
(690 references), and 1052 references were excluded after title and abstract screening. After the full-text
reading of 72 references, 22 were included in the study. Thorough snowballing yielded a further
25 studies for the screening of their abstracts, of which seven were included for full-text reading.
This resulted in a further four included studies (Figure 1). In total, 26 studies were included in this
meta-analysis [1–5,10,11,21–39].
An overview of the 26 included studies is provided in Table 2. Eighteen studies conducted CTC
following IC, six studies performed CCE following IC and two studies performed both CCE and CTC
following IC in the same group of patients (Figure 1). Therefore, patients from 20 studies were included
for CTC analyses and from eight studies for CCE analyses. Only a subgroup of patients had undergone
IC previous to CTC in seven studies of CTC, which was also the case in one CCE study (Table 2).
In those eight studies, only the subgroup in question was included for analyses. The mean age of
individuals in the included studies ranged from 57 to 81 years, with the majority of studies in the range
of 60 to 66 years. All but three studies reported the inclusion of more females than males. All CCE
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studies were from European population samples, whereas CTC studies with European, Asian and
American samples were included.
Figure 1. Flow of references from the initial literature search 10th of September 2020 on colon capsule
endoscopy vs. CT colonography following incomplete colonoscopy. CTC: computed tomography
colonography, CCE: colon capsule endoscopy and IC: incomplete colonoscopy.
Table 2. Overview of 26 studies included for meta-analysis on colon capsule endoscopy vs. CT colonography
after incomplete colonoscopy.





Hussey—2018 [10] Prospective clinical PillCam COLON 2 50 (50)
Alarcon-Fernandez—2013 [35] Prospective clinical PillCam COLON 1 34 (34)
Baltes—2019 [11] Prospective clinical PillCam COLON 2 74 (74)
Nogales—2017 [2] Prospective clinical PillCam COLON 2 96 (96)
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Table 2. Cont.




Triantafyllou—2014 [3] Prospective clinical PillCam COLON 1 75 (75)
Spada—2015 [4] Prospective clinical PillCam COLON 2 97 (97)
Deding—2020 [5] Prospective clinical PillCam COLON 2 97 (97)
Negreanu—2013 [39] Prospective clinical PillCam COLON 2 30 (70)
CTC studies
Iafrate—2008 [37] Prospective clinical




Britton—2001 [32] Prospective clinical Phillips: Tomoscan A.V.helical CT system 23 (50)
Bollart—2015 [1] Retrospective register NA 59 (297)
Maggialetti—2016 [22] Prospective clinical Toshiba: 320-row CT scanner 61 (61)
Lai—2009 [21] Retrospective chartreview
GE: multi-detector computed
tomography scanner (MDCT) 196 (764)
Neerincx—2010 [24] Prospective cohort NA 12 (511)
Ratnasingham—2017 [27] Retrospective register GE: 64 slice scanner 81 (200)
Luo—2002 [34] NA HiSpeed advantage spiralCT scanner 60 (60)
Copel—2007 [36] Retrospective chartreview
GE, MDCT: GE Lightspeed QX/i
four-section or GE Lightspeed
ultra eight-section
546 (546)
Gryspeerdt—2005 [33] Retrospective andprospective clinical GE: HiSpeed CT/i scanner 49 (49)
Macari—1999 [31] Prospective clinical GE: HiSpeed advantage scanner 10 (20)
Morrin—1999 [23] Prospective clinical GE: CT scanner or somatomplus 4 spiral CT scanner 40 (40)
Neri—2002 [30] Prospective clinical GE: single detector row spiralCT scanner 34 (54)
Neri—2010 [25] Prospective clinical GE: 4 or 64 row CT scanner 72 (72)
Pullens—2013 [26] Retrospective chartreview Philips: 16- or 64-slice MDCT 136 (136)
Salamone—2011 [28] Prospective clinical 16-detector CT scanner or dualsource CT scanner 68 (68)
Sali—2008 [29] Prospective cohort Siemens: 16-MDCT scanner(Sensation 16) 42 (42)
Spada—2015 [4] Prospective clinical GE: 64-volume CT (VCT)scanner 100 (100)
Deding—2020 [5] Prospective clinical Siemens: Somatom DefinitionEdge 64-slice CT scanner 97 (97)
O’Shea—2020 [38] Retrospective chartreview NA 245 (245)
Sample size: sample included for meta-analysis, CCE:colon capsule endoscopy, CTC: computed tomography and
NA: not available.
3.1. Completion Rate
All eight CCE studies were included for the completion rate analysis, although one was excluded
for complete colonic view [39], as it did not clearly define how this was ensured. Eleven CTC studies
were included for the completion rate analysis (Figure 2). Nine CTC studies were excluded from the
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completion rate analysis, as they did not explicitly report a completion rate or absolute numbers of
incomplete/complete investigations [1,21–24,26,33,36,37].
Figure 2. Forest plot for the completion rates of colon capsule endoscopy and CT colonography following
incomplete colonoscopy. PP: estimated prevalence proportion. Complete colonic view: CCE investigations
complete or overlapping with the most proximal point of a previous incomplete colonoscopy.
The completion rate of CCE ranged from 65 to 93%, with a pooled estimate of 0.76 (95% CI
0.68–0.84). The completion rate of CCE, defined as a complete colonic view (CCE reaches the most
proximal point of IC), ranged from 75 to 98%, with a pooled estimate of 0.90 (95% CI 0.83–0.95).
The completion rate of CTC ranged from 86 to 100%, with a pooled estimate of 0.98 (95% CI 0.96–1.00).
Heterogeneities were high in all three subgroups, with I2 at 76.61%, 80.19% and 65.96% (Figure 2).
3.2. Diagnostic Yield
Diagnostic yields were estimated and reported stratified to polyp sizes: any size, >5 mm and >9 mm.
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3.2.1. Polyps Any Size
Five CCE studies were included for the analysis (Figure 3). Two CCE studies were excluded,
as they did not report polyps <6 mm [4,5], and one study did not report the polyps per patient [3].
Eleven CTC studies were included for the analysis. Three CTC studies were excluded, as they did not
report polyps <6 mm [4,5,36]; one study only reported polyps >9 mm [37], and five studies did not
report polyps at all [28–30,32,38].
Figure 3. Forest plot of the per patient diagnostic yields for polyps of any size in colon capsule endoscopy
and in CT colonography following incomplete colonoscopy. PP: estimated prevalence proportion.
The diagnostic yield of CCE ranged from 28% to 44%, with a pooled estimate of 0.37 (95% CI
0.30–0.43). The diagnostic yield of CTC ranged from 4% to 33%, with a pooled estimate of 0.10 (95% CI
0.07–0.15). Heterogeneity may not be present in CCE analyses (I2 = 20.78%), which is supported by the
p-value of 0.28, but is substantial in CTC analyses (I2 = 62.61%) (Figure 3).
Limiting the analyses to studies published after 2009 caused no change in relation to the effect for
CCE, but in the CTC analysis, five studies were further excluded, and the pooled estimate was reduced
to 0.07 (95% CI 0.03–0.12).
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3.2.2. Polyps over 5 mm
Six CCE studies were included for analysis (Figure 4). One CCE study was excluded, as it did
not report the polyps per patient [3] and one as it grouped patients with polyps >5 mm with those
having three or more polyps of any size [2]. Seven CTC studies were included. Five CTC studies were
excluded, as they only reported any size polyps [1,21,24,26,34], five studies as they did not report
polyps at all [28–30,32,38], one as it only reported polyps >9 mm [37], one as it reported polyps any
size and polyps >9 mm [22] and one as only polyps >9 mm were reported per patient [33]. Two studies
reported polyps >4 mm and not >5 mm but were included anyway [23,25].
Figure 4. Forest plot of per patient diagnostic yields for polyps >5 mm in colon capsule endoscopy and
in CT colonography following incomplete colonoscopy. PP: estimated prevalence proportion.
The diagnostic yield of CCE ranged from 8% to 41%, with a pooled estimate of 0.21 (95% CI
0.12–0.32). The diagnostic yield of CTC ranged from 4% to 22%, with a pooled estimate of 0.13 (95% CI
0.09–0.18). Heterogeneity was substantial to considerable in the CCE analysis (I2 = 80.92%) and
moderate to substantial in the CTC analysis (I2 = 58.39%) (Figure 4).
Limiting the analyses to studies published post-2009 caused no effect for CCE, but in CTC,
analysis three studies were further excluded, and the pooled estimate was unchanged at 0.13
(95% CI 0.07–0.21)
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3.2.3. Polyps over 9 mm
Five CCE studies were included for the analysis (Figure 5). One CCE study was excluded, as it
did not report polyps per patient [3] and two as polyps >9 mm could not be differentiated from
smaller polyps [2,10]. Eight CTC studies were included. Five CTC studies were excluded, as they only
reported any size polyps [1,21,24,26,34], two as polyps >9 mm could not be differentiated from smaller
polyps [25,27] and five as they did not report polyps at all [28–30,32,38].
Figure 5. Forest plot of the per patient diagnostic yields for polyps >9 mm in colon capsule endoscopy
and in CT colonography following incomplete colonoscopy. PP: estimated prevalence proportion.
The diagnostic yield of CCE ranged from 3% to 22%, with a pooled estimate of 0.09 (95% CI
0.03–0.17). The diagnostic yield of CTC ranged from 0% to 11%, with a pooled estimate of 0.04 (95% CI
0.02–0.07). Heterogeneity was substantial to considerable in the CCE analysis (I2 = 76.89%) and
moderate to substantial in the CTC analysis (I2 = 58.16%) (Figure 5).
Limiting the analyses to studies published post-2009 caused no effect for CCE, but in the
CTC analysis, four studies were further excluded, and the pooled estimate was increased to 0.07
(95% CI 0.03–0.13).
3.3. Sensitivity
None of the included studies performed a reference standard follow-up in all patients. Most of the
studies performed colonoscopy or surgery after CCE/CTC investigations showed significant findings.
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Therefore, pooled sensitivity analyses were omitted. Two studies reported relative sensitivities
(the number of positive CCE investigations divided by the number of positive CTC investigations),
as they had performed both CCE and CTC in the same sample. The relative sensitivities of CCE
compared to CTC were reported to be 2.0 (CI 95% 1.34–2.98) and 2.67 (CI 95% 1.76–4.04) for polyps
>5 mm and 1.67 (CI 95% 0.69–4.00) and 1.91 (CI 95% 1.18–3.09) for polyps >9 mm [4,5], indicating a
higher sensitivity of CCE compared to CTC. This is a result of CCE finding substantially more polyps
compared to CTC in the same groups of patients.
3.4. Small Study Effects and Publication Bias
Egger’s test was performed for each subgroup testing for small study effects and publication bias.
Egger’s test was significant (p < 0.05) for the CCE completion rate, CCE complete colonic view rate
and CTC completion rate. For the CCE diagnostic yield, Egger’s test was not significant for polyps
of any size but was for >5-mm and >9-mm polyps. For the CTC diagnostic yield, Egger’s test was
not significant for any of the polyp size groups. Funnel plots are included in Appendix B, Figure A1.
Funnel plots from significant Egger’s tests all seem to have an overweight of studies under the
estimated effect size (skewed to the left). This may be due to publication bias, small study effects or
differing study characteristics. Publication bias, i.e., studies reporting large effect sizes, are less likely
to be published. Small study effects, i.e., that unusually high or low effect sizes are observed in smaller
study samples due to chance, which then skews the symmetry of the funnel plots. Differences between
study characteristics, such as methods or populations, i.e., study effect sizes deviating from the rest,
have included populations either more or less responsive to the investigation or have conducted the
investigation or analyses differently than their peers.
4. Discussion
The diagnostic yield of CCE for polyps of any size was almost fourfold compared to CTC.
For polyps >5 mm and >9 mm, we observed approximately twofold nonsignificant differences in the
diagnostic yields. This indicates that CCE is superior to CTC, especially in detecting small polyps.
There was insufficient empirical evidence for evaluating the sensitivity. The completion rate of CTC
(98% CI 95% 96–100%) was superior to that of CCE (76% CI 95% 68–84%), but the complete colonic view
rate of CCE was 90% (CI 95% 83–95%). As described in the introduction, the complete colonic view
rate seems appropriate for comparison with the CTC completion rate, as it completes the diagnostics.
It may be acceptable for CCE to have a slightly lower complete colonic view rate than a CTC completion
rate if more patients have polyps detected.
Some limitations to the studies in our analyses were present. The CCE studies reported completion
rates, but not all CTC studies did. If the completion rate or poor investigations were not described,
the study could not be included for the completion rate analysis. If CTC studies with nonreported
completion rates were actually due to all investigations being complete, this may have resulted in an
underestimation from our analysis. Since the pooled estimate was 98%, it could only be underestimated
by a maximum of two percentage points. Further, information on the colon distension, residue levels
in the colon and fecal tagging were not extracted or evaluated, as we believe them to be part of the
completion assessments of each investigation. The quality of the CCEs and CTCs may therefore vary
between or within studies. As the health care professionals conducting the investigations have regarded
them sufficient, they should be included in the analyses to ensure that our estimates represent reality.
Only studies in which the authors clearly stated the number of complete or incomplete investigations
were included.
Colonoscopy must be considered the reference standard for colonic polyp detection. No study
systematically performed colonoscopy after negative CCE or CTC investigations. This made it
impossible to determine whether the higher diagnostic yield of CCE was subject to bias by either a large
proportion of false-positive polyps from CCE, a large proportion of false-negative polyps from CTC
or both. Colonoscopy is not a perfect diagnostic tool for colonic polyps, and significant miss rates of
Cancers 2020, 12, 3367 12 of 17
17–25% have been reported [40–42], with a pooled estimate of 22% [43]. Therefore, when colonoscopy
does not confirm polyps, they are not necessarily false positives. Although it was not possible to
calculate the sensitivities, two studies reported the relative sensitivity of CCE compared to CTC as 2.0
and 2.7 for polyps >5 mm and as 1.7 and 1.9 for polyps >9 mm [4,5].
The diagnostic yield may differ between patient groups, i.e., screening, surveillance and
symptomatic patients, which could result in bias if one group were over- or underrepresented
in either CTC or CCE studies. This seems unlikely to be the case, as all three subgroups were heavily
represented in the included studies of each procedure.
Two CCE studies applied the first-generation capsule, whereas the remaining applied the second
(Table 2). Previously, the second-generation capsule proved more sensitive to polyps than the
first-generation capsule [44]. This may have contributed to the heterogeneity observed. When the
patterns of completion rates and diagnostic yields (Figures 2–5) are considered, it becomes evident
that only for polyps >9 mm does a first-generation PillCam study seem to perform worse than the
second. CCEs have not been conducted for as many years as CTC, resulting in a much wider timespan
of published articles regarding CTC. However, limiting the analyses to studies published after 2009
had little to no effect on the pooled estimates.
Our methods also hold some limitations. Heterogeneities were present in most of the analyses,
indicating the presence of variances between the studies. Egger’s tests were significant in several
analyses, indicating the presence of publication bias and/or small study effects. The results should
therefore be interpreted with these limitations in mind. No quality assessment, other than fulfilling the
inclusion criteria, was made. We extracted raw data from the studies and calculated the completion rate
and diagnostic yield. If a study used an inappropriate way of analyzing the data, it would therefore
not affect our results, as we systematically treated the raw data equally. The possible inclusion of
low-quality studies could affect the estimates and lead to heterogeneity, but lower quality studies
would have to be underestimating the effects of CTC and overestimating the effects of CCE to explain
the observed differences, and the Eggers plots do not suggest this to be true. It is possible that reaching
out to authors of excluded papers could have led to the inclusion of more studies, although with a risk
of bias if certain authors were more likely to respond or share data. This was omitted, since it was our
desire to have a nondifferential approach to all articles identified. Moreover, our study approach was
very systematic, with clearly defined inclusion criteria, and no study was included unless we were
certain that we could identify and extract the data needed for our analyses. Expanding the literature
search to additional scientific research databases or systematically adding keywords from studies
identified through snowballing might also have increased the number of included studies, but since
thorough snowballing was conducted and further repeated in the newly identified studies, we believe
that the search reached the point of exhaustion.
CTC may be more reliable for larger polyps than smaller polyps [9,45]. This was also confirmed
by our meta-analysis, as the difference in the diagnostic yield between CCE and CTC was reduced
when limiting the analyses to polyps >5 mm and >9 mm. CTC and CCE have the drawback of being
diagnostic investigations, as a positive test result would have to be followed by therapeutic procedures.
IC, as well as standard colonoscopy, can be very painful, and sometimes, pain is even the reason for
incompletion [5]. Therefore, patients may prefer to have a confirmed finding prior to further colonoscopy
attempts. Patient preference should also be considered when comparing CTC and CCE, as bowel
preparation regimens and the nature of the investigations differ substantially. Implementing CCE
would require trained CCE readers. Training would therefore need to be incorporated alongside
training in traditional endoscopy. CTC usually includes a simpler bowel preparation; is able to
identify extracolonic findings not available from CCE (e.g., hepatic and renal cysts, lung nodules,
adrenal adenomas and extracolonic malignancy); is less costly; is more widely available compared to
CCE and does not include the ingestion of equipment. CCE seems preferred by patients [15], spares the
patient unnecessary radiation and is possible to conduct in the same unit (without referral to another
clinic in the same or another hospital) or even in the privacy of their own home.
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5. Conclusions
This meta-analysis of CCE vs. CTC following IC indicates that a complete CCE after IC is
not inferior to CTC in detecting polyps. The completion rate of CTC was higher than that of CCE.
However, when comparing the complete colonic view rate of CCE to the CTC completion rate,
the difference was reduced. The diagnostic yield for any size polyps was almost fourfold in CCE
compared to CTC and twofold, but statistically insignificant, in medium-large and large-sized polyps.
The increased diagnostic yield of CCE could outweigh its slightly lower complete colonic view rate
compared to the superior CTC completion rate. Hence, CCE following IC appears feasible for an
introduction to clinical practice. Therefore, randomized studies investigating CCE and/or CTC following
incomplete colonoscopy with a reference standard for the entire population, enabling estimates for
sensitivity and specificity, are needed. The empirical evidence is still scarce, especially for CCE, and the
analyses should be repeated when more studies are available.
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Web of Science: 524 Hits (661 before Limiting to Articles)
ALL = (“Capsule endoscop*” OR “Camera endoscop*” OR WCE* OR PillCam* OR “Pill cam*” OR
“camera pill*” OR “capsule camera*” OR “wireless camera*” OR “Endoscopic capsule*” OR “endoscopy
capsule*” OR CCE* OR Colonograph* OR CTC*) AND ALL = (Colonoscop*) AND ALL = (Cohort OR
“Randomized controlled trial*” OR RCT* OR case-control OR “case control” OR paired OR prospective)
PubMed: 739 Hits (754 before Limiting to Journal Articles)
(“Capsule endoscop*” OR “Camera endoscop*” OR WCE OR PillCam* OR “Pill cam*” OR “camera
pill*” OR “capsule camera*” OR “wireless camera*” OR “Endoscopic capsule*” OR “endoscopy capsule*”
OR CCE OR “Capsule Endoscopy” (mh) OR “Capsule Endoscopes” (mh) OR Colonograph* OR CTC
OR “Colonography, Computed Tomographic” (mh)) AND (Colonoscop* OR Colonoscopy (mh)) AND
(cohort OR “Randomized controlled trial*” OR RCT OR case-control OR “case control” OR paired OR
prospective OR “Cohort Studies” (mh) OR “Randomized Controlled Trial” (mh) OR “Case-Control
Studies” (mh) OR “Matched-Pair Analysis” (mh) OR “Prospective Studies” (mh))
Embase: 551 Hits (1122 before Limiting to Articles)
((“Capsule endoscop*” or “Camera endoscop*” or WCE* or PillCam* or “Pill cam*” or “camera
pill*” or “capsule camera*” or “wireless camera*” or “endoscopic capsule*” or “endoscopy capsule*” or
CCE* or capsule endoscope/ or capsule endoscopy/ or colonograph* or CTC* or computed tomographic
colonography/) and (Colonoscop* or colonoscopy/) and (cohort or “Randomized controlled trial*” or
RCT* or case-control or “case control” or paired or prospective or cohort analysis/ or randomized
controlled trial/ or case control study/ or prospective study/))
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Table A1. Search strategy to identify the relevant studies on colon capsule endoscopy vs. CT colonography
following incomplete colonoscopy.
AND












































*—truncation identifying all terms regardless of term form. (mh)—Medical Subject Heading (MeSH) used in
PubMed/—Subject Heading used in Embase.
Appendix B
Figure A1. Funnel plots from Egger’s tests visualizing the symmetry of the effect sizes within each
sub-analysis from the meta-analysis on colon capsule endoscopy vs. CT colonography following
incomplete colonoscopy.
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